In recent years, Boron Neutron Capture Therapy (BNCT) has emerged as a cutting-edge cancer treatment technology, experiencing rapid development globally. Neuboron Medical Group (Neuboron), a leading...

The Fertility Institute is excited to announce the addition of Dr. Nicole Ulrich, M.D., to its team as an experienced Reproductive Endocrinologist and fertility specialist. With her exceptional...

Receiving a breast cancer diagnosis is a life-changing moment, and the journey through treatment can often feel overwhelming. From managing complex therapies and coping with side effects to staying...

Opill®— the first and only daily birth control pill available without a prescription in the U.S. —launched an educational college campus tour and the next phase of its multiyear partnership with the...

Tempe K. Chen, M.D., a distinguished pediatric infectious disease specialist from Miller Children's & Women's Hospital in Long Beach, Calif., has been recognized as a Fellow by both the Infectious...

Nymi, Inc. announced the launch of its next-generation wearable authenticator, the Nymi Band 4, which introduces design upgrades and expanded passwordless use cases for regulated industries, while...

Essen Health Care is proud to announce its selection by the Centers for Medicare & Medicaid Services (CMS) to participate in the groundbreaking Guiding an Improved Dementia Experience (GUIDE) Model, a new...

Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, today announced the immediate commercial launch and FDA 510(k) clearance and CE Mark for Norlase®...

USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 in San Francisco. This year's event is...

CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection...

USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief...

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based investigational gene therapy aimed at treating retinal dystrophy in patients with...